Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Asset Writedowns and Impairment (2019 - 2023)

Lifecore Biomedical, Inc. \De\ has reported Asset Writedowns and Impairment over the past 8 years, most recently at -$1.4 million for Q2 2024.

  • For Q2 2024, Asset Writedowns and Impairment fell 207.85% year-over-year to -$1.4 million; the TTM value through May 2024 reached $2.3 million, down 95.28%, while the annual FY2023 figure was $1.3 million, 98.34% down from the prior year.
  • Asset Writedowns and Impairment for Q2 2024 was -$1.4 million at Lifecore Biomedical, Inc. \De\, down from $1.4 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $46.1 million in Q2 2022 and troughed at -$1.4 million in Q2 2024.
  • A 5-year average of $7.2 million and a median of $300000.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: skyrocketed 47656.72% in 2021 and later tumbled 207.85% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $67000.0 in 2020, then skyrocketed by 47656.72% to $32.0 million in 2021, then plummeted by 99.06% to $300000.0 in 2022, then skyrocketed by 333.33% to $1.3 million in 2023, then tumbled by 207.85% to -$1.4 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for LFCR at -$1.4 million in Q2 2024, $1.4 million in Q1 2024, and $1.3 million in Q2 2023.